High-sensitivity C-reactive protein predicts mortality but not stroke: The Northern Manhattan Study

Neurology

Volumn 73, Issue 16, 2009, Pages 1300-1307

  Elkind, M S V ^a   Luna, J M ^a   Moon, Y P ^a   Liu, K M ^a   Spitalnik, S L ^a,b   Paik, M C ^c   Sacco, R L ^d,e  

^a Department of Neurology ^*

^b Department of Pathology ^*  (United States)

^c Division of Biostatistics

^d Department of Epidemiology ^*  (United States)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID A PROTEIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; FEMALE; HEART INFARCTION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NEPHELOMETRY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RISK FACTOR; STROKE;

AGED; BRAIN ISCHEMIA; C-REACTIVE PROTEIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MYOCARDIAL INFARCTION; NEPHELOMETRY AND TURBIDIMETRY; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SERUM AMYLOID A PROTEIN; STROKE;

EID: 72249084311     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181bd10bc     Document Type: Article

References (35)

1. Di Napoli M, Schwaninger M, Cappelli R, et al. Evaluation of C-reactive protein measurement for assessing risk and prognosis in ischemic stroke: a statement for healthcare professional from the CRP Pooling Project member. Stroke 2005;36:1316-1329.
2. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511.
3. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently health women. Circulation 1998;98:731-733.
4. Rost NS, Wolf PA, Kase CS, et al. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke 2001;32: 2575-2579.
5. Everett BM, Kurth T, Buring JE, Ridker PM, et al. The relative strength of C-reactive protein and lipid levels as determinants of ischemic stroke compared with coronary heart disease in women. J Am Coll Cardiol 2006;48:2235-2242.
6. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hen-nekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-979.
7. Anand SS, Razak F, Yi Q, et al. C-reactive protein as a screening test for cardiovascular risk in a multiethnic population. Arterioscler Thromb Vasc Biol 2004;24:1509-1515.
8. Yamada S, Gotoh T, Nakashima Y, et al. Distribution of serum C-reactive protein and its association with atherosclerotic risk factors in a Japanese population: Jichi Medical School cohort study. Am J Epidemiol 2001; 153:1183-1190.
9. Kelley-Hedgepeth A, Lloyd-Jones DM, Colvin A, et al. Ethnic differences in C-reactive protein concentrations. Clin Chem 2008;54:1027-1037.
10. Tracy RP, Lemaitre RN, Psaty BM, et al. Relationship of C-reactive protein to risk of cardiovascular risk: results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc 1997;17:1121-1127.
11. Ridker PM. High-sensitivity C-reactive protein as a predictor of all-cause mortality: implication for research and patient care. Clin Chem 2008;54:234-237.
12. Sacco RL, Anand K, Lee HS, et al. Homocysteine and the risk of ischemic stroke in a tri-ethnic cohort: the Northern Manhattan Study. Stroke 2004;35:2263-2269.
13. Gentry EM, Kalsbeek WD, Hogelin GC, et al. The Behavioral Risk Factor Surveys, II: design, methods, and estimate from combined state data. Am J Prev Med 1985;1:9-14.
14. Greene HL, Richardson DW, Barker AH, et al; CAPS Investigators. Classification of deaths after myocardial infarction as arrhythmic and nonarrhythmic (the Cardiac Arrhythmia Pilot Study). Am J Cardiol 1989;63:1-6.
15. Morris DL, Kritchevsky SB, Davis CE. Serum carotenoid and coronary heart disease: the Lipid Research Clinics Coronary Primary Prevention Trial and Follow-up Study. JAMA 1994;272:1439-1441.
16. Wang CY, Chen HY. Augmented inverse probability weighted estimator for Cox regression missing covariate regression. Biometrics 2001;57:414-419.
17. Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008;359:2195-2207.
18. Marsik C, Kazemi-Shirazi L, Schickbauer T, et al. C-reactive protein and all-cause mortality in a large-hospital based cohort. Clin Chem 2008;54:343-349.
19. Clarke R, Emberson JR, Breeze E, et al. Biomarkers of inflammation predict both vascular and non-vascular mortality in older men. Eur Heart J 2008;29:800-809.
20. Curb JD, Abbott RD, Rodriguez BL, et al. C-reactive protein and the future of thromboembolic stroke in health men. Circulation 2003;107:2016-2020.
21. Wakugawa Y, Kiyohara Y, Tanizaki Y, et al. C-reactive protein and the risk of first ever ischemic and hemorrhagic stroke in a general Japanese population: the Hismaya Study. Stroke 2005;37:27-32.
22. Cao JJ, Thach C, Manolio TA, et al. C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: the Cardiovascular Health Study. Circulation 2003;108:166-170.
23. Cesari M, Penninx BW, Newman AB, et al. Inflammatory markers and onset of cardiovascular events results from the Health ABC Study. Circulation 2003;108:2317-2322. (Pubitemid 37413536)
24. Makita S, Nakamura M, Satoh K, et al. Serum C-reactive protein levels can be used to predict future ischemic stroke and mortality in Japanese men from the general population. Atherosclerosis Epub 2008 Aug 12.
25. Shen J, Arnett DK, Parnell LD, et al. Association of common C-reactive protein (CRP) gene polymorphisms with baseline plasma CRP levels and fenofibrate response: the GOLDN Study. Diabetes Care 2008;31:910-915.
26. Litton E, Ho KM, Chamberlain J, Dobb GJ, Webb SA. C-reactive protein concentration as a predictor of in-hospital mortality after ICU discharge: a nested-case control study. Critical Care Resusc 2007;9:19-25.
27. Harris T. Association of elevated interleukim-6 and C-reactive protein levels with mortality in the elderly. Am J Med 1999;106:506-512.
28. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002;55:445-451.
29. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-843. (Pubitemid 30165206)
30. Yeh ET, Willerson JT. Coming of age of C-reactive protein: using inflammation markers in cardiology. Circulation 2005;107:370-371.
31. Poole S, Walker D, Gaines Das RE, Gallimore JR, Pepys MB. The first international standard for serum amyloid A protein (SAA): evaluation in an international collaborative study. J Immunological Methods 1998;214:1-10.
32. Johnson BD, Kip KE, Marroquin OC, et al. Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 2004;109:726-732.
33. Morrow DA, Rifai N, Antman EM, et al. Serum amyloid A predicts early mortality in acute coronary syndromes: a TIMI 11A substudy. J Am Coll Cardiol 1999;35:358-362.
34. Vidula H, Tian L, Liu K, et al. Biomarkers of inflammation and thrombosis as predictors of near-term mortality in patients with peripheral arterial disease: a cohort study. Ann Intern Med 2008;148:85-93.
35. Elkind MS, Leon V, Moon YP, Paik MC, Sacco RL. High-sensitivity C-reactive protein and lipoprotein-associated phospholipase A2 stability before and after stroke and myocardial infarction. Stroke (in press 2009).